Label: MECLIZINE HCL 25 MG- meclizine hydrochloride tablet, chewable

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated February 9, 2022

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredient (in each chewable tablet)

    Meclizine HCl, USP 25 mg

  • PURPOSE

    Purpose

    Antiemetic

  • INDICATIONS & USAGE

    Uses

    prevents and treats nausea, vomiting or dizziness due to motion sickness

  • WARNINGS

    Warnings

  • DO NOT USE

    Do not use in children under 12 years of age unless directed by a doctor.

  • ASK DOCTOR

    Ask a doctor before use if you have

    • glaucoma
    • a breathing problem such as emphysema or chronic bronchitis
    • trouble urinating due to an enlarged prostate gland
  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

  • WHEN USING

    When using this product

    • may cause drowsiness
    • alcohol, sedatives and tranquilizers may increase drowsiness
    • avoid alcoholic drinks
    • use caution when driving a motor vehicle or operating machinery
  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

    In case of overdose, get medical help or contact the poison control center immediately.

  • DOSAGE & ADMINISTRATION

    Directions

    • dosage should be taken one hour before travel starts.
    • adults and children 12 years of age and older: Chew 1-2 tablets once daily or as directed by a doctor
    • children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor
  • STORAGE AND HANDLING

    Other information

    • phenylketonurics: contains phenylalanine 0.28 mg per tablet
    • store at room temperature in a dry place
  • INACTIVE INGREDIENT

    Inactive ingredients Aspartame, croscarmellose sodium, dextrose, FD&C red #40 lake, magnesium stearate, maltodextrin, microcrystalline cellulose, natural and artificial flavors, silicon dioxide, sodium sulfate, sugar, tricalcium phosphate.

  • QUESTIONS

    Questions? If you have any questions or comments or to report an adverse event, please contact (800) 795-9775.

  • SPL UNCLASSIFIED SECTION

    Distributed by: Plus Pharma, Commack, NY 11725

    *Plus Pharma is not affiliated with the owner of the registered trademark Bonine®.

  • HOW SUPPLIED

    NDC: 71335-0143-1: 30 Tablets in a BOTTLE

    NDC: 71335-0143-2: 20 Tablets in a BOTTLE

    NDC: 71335-0143-3: 25 Tablets in a BOTTLE

    NDC: 71335-0143-4: 40 Tablets in a BOTTLE

    NDC: 71335-0143-5: 60 Tablets in a BOTTLE

    NDC: 71335-0143-6: 90 Tablets in a BOTTLE

    NDC: 71335-0143-7: 8 Tablets in a BOTTLE

    NDC: 71335-0143-8: 14 Tablets in a BOTTLE

    NDC: 71335-0143-9: 10 Tablets in a BOTTLE

    NDC: 71335-0143-0: 120 Tablets in a BOTTLE

  • PRINCIPAL DISPLAY PANEL

    Meclizine 25MG Chewable

    Label
  • INGREDIENTS AND APPEARANCE
    MECLIZINE HCL 25 MG 
    meclizine hydrochloride tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71335-0143(NDC:51645-994)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTAME (UNII: Z0H242BBR1)  
    SUCROSE (UNII: C151H8M554)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SODIUM SULFATE (UNII: 0YPR65R21J)  
    TRICALCIUM PHOSPHATE (UNII: K4C08XP666)  
    Product Characteristics
    Colorpink (Uncoated) Score2 pieces
    ShapeROUND (Biconvex) Size8mm
    FlavorRASPBERRYImprint Code 21G
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71335-0143-130 in 1 BOTTLE; Type 0: Not a Combination Product03/15/2018
    2NDC:71335-0143-220 in 1 BOTTLE; Type 0: Not a Combination Product03/05/2018
    3NDC:71335-0143-325 in 1 BOTTLE; Type 0: Not a Combination Product01/04/2019
    4NDC:71335-0143-440 in 1 BOTTLE; Type 0: Not a Combination Product10/26/2018
    5NDC:71335-0143-560 in 1 BOTTLE; Type 0: Not a Combination Product02/09/2022
    6NDC:71335-0143-690 in 1 BOTTLE; Type 0: Not a Combination Product02/19/2018
    7NDC:71335-0143-78 in 1 BOTTLE; Type 0: Not a Combination Product04/27/2018
    8NDC:71335-0143-814 in 1 BOTTLE; Type 0: Not a Combination Product02/09/2022
    9NDC:71335-0143-910 in 1 BOTTLE; Type 0: Not a Combination Product02/09/2022
    10NDC:71335-0143-0120 in 1 BOTTLE; Type 0: Not a Combination Product03/13/2018
    Image of Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart33610/15/2015
    Labeler - Bryant Ranch Prepack (171714327)
    Registrant - Bryant Ranch Prepack (171714327)
    Establishment
    NameAddressID/FEIBusiness Operations
    Bryant Ranch Prepack171714327REPACK(71335-0143) , RELABEL(71335-0143)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!